Brief: Mersana Therapeutics Q3 EPS USD -0.35
Nov 07 (Reuters) - Mersana Therapeutics Q3 collaboration revenue USD 7.698 million. * Q3 net income USD -41.656 million
Nov 07 (Reuters) - Mersana Therapeutics Q3 collaboration revenue USD 7.698 million. * Q3 net income USD -41.656 million